> ## Content Index > Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt > Use this file to discover other available public pages before exploring further. # Qu Biologics - URL: https://www.whiteroseintelligence.com/qu-biologics/ - Published: 1999-01-02T23:00:00.000Z - Updated: 2025-07-02T03:08:42.000Z - Author: Liam Sturgess - Tags: Profiles, #docs, #organization **Qu Biologics, Inc.** is a Canadian biotechnology company based in Burnaby, British Columbia. ## History Qu Biologics was founded in 2007 by Hal Gunn and Rob Freeman.[\[1\]](#fn1) ### COVID-19 On December 18, 2020, the [National Research Council Canada](https://www.whiteroseintelligence.com/National-Research-Council-Canada) announced up to $109,764.00 in funding through the Industrial Research Assistance Program (NRC IRAP) to Qu Biologics "for a project to provide proof-of-concept evidence for the safety and efficacy of a preventative treatment as well as therapeutic use of a treatment to protect the lungs and prevent serious COVID-19 infection."[\[2\]](#fn2) ## Organization Qu Biologics is a member organization of the [Biotechnology Innovation Organization](https://www.whiteroseintelligence.com/Biotechnology-Innovation-Organization) (BIO) and N2 Canada.[\[3\]](#fn3)[\[4\]](#fn4) ### Funding Since 2007, Qu Biologics has “raised over CAD$40 million in funding from private investors and government funding”.[\[5\]](#fn5) The company has received grants and investment funding from:[\[6\]](#fn6)[\[7\]](#fn7) - Asian Capital Alliance (ACA Group) - [David Lopez](https://www.whiteroseintelligence.com/David-Lopez)[\[8\]](#fn8) - Harmonix Fund - [Integro Capital](https://www.whiteroseintelligence.com/Integro-Capital)[\[9\]](#fn9) - [National Research Council Canada](https://www.whiteroseintelligence.com/National-Research-Council-Canada)'s Industrial Research Assistance Program (NRC IRAP) ### Team | Name | Position | Notes | | ---------------------------------------------------------------------- | ----------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | | Hal Gunn | CEO and Founder[\[10\]](#fn10) | InspireHealth, University of British Columbia (UBC) | | Simon Sutcliffe | Chief Medical Officer - Oncology | Princess Margaret Hospital | | Ted Steiner | Chief Medical Officer - Infectious Diseases | University of British Columbia | | Matt Cahill | Chief Operating Officer | [Deep Genomics](https://www.whiteroseintelligence.com/Deep-Genomics), University of Toronto | | Shirin Kalyan | Vice President, Scientific Innovation | Alexander von Humboldt Foundation, University of British Columbia | | David Mullins | Chief Scientific Officer (former) | Norris Cotton Cancer Center | | Gillian Vandermeirsch | Vice President of Operations (former) | Pasteur Institute | | Bob Cory | Vice President of Business Development (former) | Bioasis Technologies, MIGENIX, Illumigen Biosciences | | Julie Jang | Director of Communications (former) | Sirona Biochem, Zalicus | | Heidi Biagi | Director of Project Management (former) | Novadeq Technologies, QLT | | Russell McAllister | Vice President of Finance (former) | Lakewood-Amedex, H.C. Wainwright & Co., Thomas Weisel Partners, Merriman Curhan Ford & Co., PricewaterhouseCoopers | | Jim Pankovich | Vice President of Clinical Operations & Drug Development (former) | MIGENIX, [Inex Pharmaceuticals](https://www.whiteroseintelligence.com/Inex-Pharmaceuticals), CV Technologies | | Kevin Harper | Acting Director of Manufacturing (former) | HH Consultancy, Sanofi Pasteur, Novartis | | Nicole Clendinning | Director of Finance (former) | Chartered Professional Accountants of British Columbia | | Alun Rees | Vice President of Manufacturing (former) | STEMCELL Technologies, QLT, GlaxoSmithKline, Bio Products Laboratories (BPL) | | Mark Bazett | Director of Preclinical and Translational Research (former) | Meakins-Christie Laboratories | | Julia Levy | Board member[\[11\]](#fn11) | QLT, Foundation Fighting Blindness, Wilmer Eye Institute, Life Sciences British Columbia, University of British Columbia | | Karn Manhas | Board member | Terramera, Young Presidents' Organization (YPO), [Unreasonable Group](https://www.whiteroseintelligence.com/Unreasonable-Group) | | Mike Leschuk | Board member | Leschuk-Weisz Developments, Rob Freeman Foundation, PricewaterhouseCoopers, London Telecom Group | | [Foster Coulson](https://www.whiteroseintelligence.com/Foster-Coulson) | Board member | [Integro Capital](https://www.whiteroseintelligence.com/Integro-Capital) | | Marc Lambiotte | Board member | West Coast General Hospital | | Dieter Kabelitz | Scientific Advisor[\[12\]](#fn12) | University of Kiel, German Society of Immunology, International Union of Immunological Societies, Rockefeller University, University of Heidelberg, Paul Ehrlich Institute | | Bruce Vallance | Scientific Advisor | Child & Family Research Institute (CFRI), Crohn’s and Colitis Canada, CH.I.L.D. Foundation, British Columbia Children's Hospital, University of British Columbia | | Balfour Sartor | Scientific Advisor | University of North Carolina at Chapel Hill, Crohn's & Colitis Foundation | | Michael Noble | Scientific Advisor | University of British Columbia | | Robert E.W. Hancock | Scientific Advisor | University of British Columbia, MIGENIX, Inimex Pharmaceuticals, ABT Innovations, Sepset Biotherapeutics, Centre for Drug Research and Development (CDRD) | | Brian Feagan | Clinical Advisor[\[13\]](#fn13) | Schulich School of Medicine & Dentistry, London Health Sciences Centre, Robarts Research Institute | | William Sandborn | Clinical Advisor | University of California, San Diego, UC San Diego Health System, Mayo Clinic | | Brian Bressler | Clinical Advisor | University of British Columbia, Massachusetts General Hospital, Harvard Medical School | | John Marshall | Clinical Advisor | McMaster University, Hamilton Health Sciences | ## External links - [Campfire Wiki](https://www.campfire.wiki/doku.php?id=pharmaceutical%5Fcompanies:qu%5Fbiologics) - [Crunchbase](https://www.crunchbase.com/organization/qu-biologics-inc) - [LinkedIn](https://www.linkedin.com/company/qu-biologics-inc/) - [Website](https://www.qubiologics.com/) --- 1. *Our History.* Qu Biologics Inc. Retrieved May 1, 2023, from [↩︎](#fnref1) 2. *National Research Council of Canada supports development of 4 COVID-19 therapeutic candidates.* (2020, December 18). Government of Canada. [↩︎](#fnref2) 3. *BIO Member Directory.* Biotechnology Innovation Organization. Retrieved September 30, 2022, from [↩︎](#fnref3) 4. *Members.* N2 Canada. Retrieved October 11, 2022, from [↩︎](#fnref4) 5. *Our History.* Qu Biologics Inc. Retrieved May 1, 2023, from [↩︎](#fnref5) 6. *Qu Biologics Inc. - Funding, Financials, Valuation & Investors.* Crunchbase. Retrieved May 1, 2023, from [↩︎](#fnref6) 7. *Portfolio.* ACA Group. Retrieved May 1, 2023, from [↩︎](#fnref7) 8. *Experience | Dave Lopez.* LinkedIn. Retrieved July 19, 2023, from [↩︎](#fnref8) 9. *Home.* Integro Capital. Retrieved July 19, 2023, from [↩︎](#fnref9) 10. *Management Team.* Qu Biologics Inc. Retrieved May 2, 2023, from [↩︎](#fnref10) 11. *Board of Directors.* Qu Biologics Inc. Retrieved May 2, 2023, from [↩︎](#fnref11) 12. *Scientific Advisory Board.* Qu Biologics Inc. Retrieved May 7, 2023, from [↩︎](#fnref12) 13. *IBD Clinical Advisors.* Qu Biologics Inc. Retrieved May 7, 2023, from [↩︎](#fnref13)